Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Metastatic disease remains invariably fatal. Until truly curative therapies are developed, can clinical oncology benefit from lessons learned in pest management?
Land policies around the world tend to focus on support for agricultural output. We argue that this leads to ineffective public expenditure, environmental harm and missed opportunities for the use of rural resources. Applying thinking centred on ecosystems services to the governance of rural land would secure greater social value.
As Bolivia approaches presidential elections in October 2019, the country’s environmental leadership is at stake. We discuss urgent challenges and opportunities for reconciling conservation and societal needs in this mega-diverse country.
The IPBES global assessment has brought biodiversity prominently to the attention of policymakers and the public, and researchers should seize this critical opportunity to engender change towards sustainability.
Current mangrove planting schemes aimed at reversing global losses are prioritising short-term increases in area over long-term establishment. Without sound, evidence-based restoration policies, this approach could accelerate the demise of mangrove forests and the ecosystem services they provide.
The editors of Nature Ecology & Evolution are always keen to hear about your research and answer your questions, and you can approach us at conferences or contact us via e-mail at any time.
The inauguration of Jair Bolsonaro as Brazil’s new president has heralded a rapid acceleration of the erosion of environmental protection measures in the country. Brazil’s scientific community should rally to provide evidence that this is economically and socially unwise.
New antibiotics are urgently needed to combat rising rates of resistance against all existing classes of antimicrobials. We highlight key issues that complicate the prediction of resistance evolution in the real world and outline the ways in which these can be overcome.